(71) have reported that IO upregulates the expression of IL-6, IL-8, TGFβ and VEGF in MDS-derived BM-MSCs through ROS upregulation and subsequent HIF-1a overexpression (71). The gene discussed is TGFB1; the disease is myelodysplastic syndrome.